Slc26a9-KO Mouse
一般名
Slc26a9-KO
製品ID
S-KO-18553
背景情報
C57BL/6JCya
系統ID
KOCMP-320718-Slc26a9-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Slc26a9-KO Mouse(カタログ番号S-KO-18553)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Slc26a9-KO
系統ID
KOCMP-320718-Slc26a9-B6J-VB
遺伝子名
製品ID
S-KO-18553
遺伝子別名
E030002L01Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 1
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000049027
NCBIトランスクリプトID
NM_177243
ターゲット領域
Exon 3~5
有効領域の大きさ
~2.3 kb
遺伝子研究の概要
Slc26a9 is a member of the SLC26A family of anion transporters, functioning as a Cl-transporter across various epithelia [1,2,3,4,5,6,7,8,9,10]. It is involved in ion transport mechanisms and plays a role in maintaining acid-base homeostasis, especially in epithelia where it mediates Cl-absorption and HCO3-secretion [8]. It has been associated with pathways like Wnt/β-catenin signaling, and is of biological importance in multiple organs including the respiratory system, gastrointestinal tract, male tissues, and skin [1,3,6]. Genetic models such as gene-knockout (KO) mouse models have been crucial in studying its functions [1,6].
In Slc26a9-knockout animals, neonatal distress and early death occur, likely due to its role in fluid reabsorption in the alveolar space [1]. In the gastrointestinal tract, Slc26a9-deficient mice show spontaneous development of gastric premalignant and malignant lesions, with dysregulated differentiation of gastric stem cells, activated Wnt signaling, hyperproliferation, apoptosis inhibition, and metaplasia [6]. In colorectal cancer cell lines and mouse models, down-regulation of Slc26a9 induced cell cycle arrest and apoptosis, while inhibiting cell proliferation and xenograft tumor growth, indicating its role in promoting colorectal tumorigenesis through modulating Wnt/β-catenin signaling [3].
In conclusion, Slc26a9 is essential for maintaining proper ion and fluid balance in multiple organs. The study of Slc26a9 KO mouse models has revealed its role in various disease conditions, such as neonatal distress, gastric intraepithelial neoplasia, and colorectal cancer. Understanding its functions provides new possibilities for disease therapy, especially in diseases related to abnormal ion transport and epithelial cell homeostasis [1,3,6,8].
References:
1. Kunzelmann, Karl, Centeio, Raquel, Ousingsawat, Jiraporn, Seidler, Ursula, Schreiber, Rainer. . SLC26A9 in airways and intestine: secretion or absorption? In Channels (Austin, Tex.), 17, 2186434. doi:10.1080/19336950.2023.2186434. https://pubmed.ncbi.nlm.nih.gov/36866602/
2. Gorrieri, Giulia, Zara, Federico, Scudieri, Paolo. 2022. SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease. In Biomolecules, 12, . doi:10.3390/biom12020202. https://pubmed.ncbi.nlm.nih.gov/35204703/
3. Zhang, Minglin, Ma, Zhiyuan, Yi, Zhiqiang, Li, Taolang, Liu, Xuemei. 2024. SLC26A9 promotes colorectal tumorigenesis by modulating Wnt/β-catenin signaling. In Cell death discovery, 10, 123. doi:10.1038/s41420-024-01888-6. https://pubmed.ncbi.nlm.nih.gov/38461207/
4. Kunzelmann, Karl, Ousingsawat, Jiraporn, Kraus, Andre, Schreiber, Rainer, Buchholz, Björn. 2023. Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins. In International journal of molecular sciences, 24, . doi:10.3390/ijms241713278. https://pubmed.ncbi.nlm.nih.gov/37686084/
5. Ousingsawat, Jiraporn, Centeio, Raquel, Schreiber, Rainer, Kunzelmann, Karl. 2022. Expression of SLC26A9 in Airways and Its Potential Role in Asthma. In International journal of molecular sciences, 23, . doi:10.3390/ijms23062998. https://pubmed.ncbi.nlm.nih.gov/35328418/
6. Liu, Xuemei, Li, Taolang, Ma, Zhiyuan, Seidler, Ursula, Tuo, Biguang. 2022. SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans. In Cellular oncology (Dordrecht, Netherlands), 45, 381-398. doi:10.1007/s13402-022-00672-x. https://pubmed.ncbi.nlm.nih.gov/35426084/
7. Balázs, Anita, Mall, Marcus A. 2018. Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis. In Frontiers in pharmacology, 9, 1112. doi:10.3389/fphar.2018.01112. https://pubmed.ncbi.nlm.nih.gov/30327603/
8. Liu, Xuemei, Li, Taolang, Tuo, Biguang. 2018. Physiological and Pathophysiological Relevance of the Anion Transporter Slc26a9 in Multiple Organs. In Frontiers in physiology, 9, 1197. doi:10.3389/fphys.2018.01197. https://pubmed.ncbi.nlm.nih.gov/30233393/
9. Pinto, Madalena C, Quaresma, Margarida C, Silva, Iris A L, Ramalho, Sofia S, Amaral, Margarida D. 2021. Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9. In International journal of molecular sciences, 22, . doi:10.3390/ijms222313064. https://pubmed.ncbi.nlm.nih.gov/34884866/
10. Needham, Patrick G, Goeckeler-Fried, Jennifer L, Zhang, Casey, Bertrand, Carol A, Brodsky, Jeffrey L. . SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain. In The Biochemical journal, 478, 4203-4220. doi:10.1042/BCJ20210644. https://pubmed.ncbi.nlm.nih.gov/34821356/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
